John Freund
8Patents
2h-index
7Co-inventors
40Inventor score
Filing activity: Dec 20, 2010 → Apr 6, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9814744B2 | Decellularized adipose cell growth scaffold | Chemistry; Metallurgy | 11 | Active |
| US10085999B1 | Beta-lactamase inhibitors and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US10280161B2 | Aztreonam derivatives and uses thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US11565999B2 | Methods of synthesizing aztreonam derivatives | Human Necessities | 0 | Active |
| US10815228B2 | Aztreonam derivatives and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US10722521B2 | Beta-lactamase inhibitors and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11180500B2 | Derivatives of relebactam and uses thereof | Human Necessities | 0 | Active |
| US10500211B2 | Beta-lactamase inhibitors and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.